The criteria for optimizing the success of a Sonocur™ Treatment for near bone pain are:
Although most diagnosis of shoulder pain, tendonitis, heel spur and other types of near bone pain are made on the basis of a clinical exam and history, one should also remember the possibility of rare or unusual pathology.
The only significant risk to Extracorporeal Shockwave Therapy is the treatment of unknown malignant or other rare pathological condition, thus delaying definitive diagnosis and effective medical therapy.
Therefore all patients should have an appropriate imaging study (x-ray, CT scan, MRI, etc.) prior to Sonocur treatment in order to rule out this possibility. No patient should be treated without an imaging study report being available unless the referring physicians signs a specific referral request indicating that no x-ray or other study is needed in his/her professional judgment or in view of his/her previous evaluation of that particular patient.
The Sonocur® Orthopedic Extracorporeal Shockwave system is available in Canada and other countries where regulatory approval has been obtained. The Sonocur® Basic is FDA approved in the United States for the treatment of chronic lateral epicondylitis (tennis elbow).
© 2012 Sonorex. All rights reserved. By using this service, you accept the terms of our Visitor Agreement. Please read it. The material sonorex.ca is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.